AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Milestone Scientific Q2 revenue up 35% YoY, hosts conference call on Aug 15.
ByAinvest
Wednesday, Aug 13, 2025 11:49 am ET1min read
• Milestone Scientific reports Q2 financial results on August 15th, 2025. • Webcast and replay available at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/52876. • Audio replay available until August 29th, 2025.
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, has scheduled its Q2 2025 financial results conference call for Friday, August 15, 2025, at 8:00 AM ET [1].The call will provide insights into the company's financial performance during the second quarter ended June 30, 2025, as well as updates on corporate progress and other developments. Investors can participate via phone (U.S. toll-free: 888-506-0062; International: +1 973-528-0011; Access code: 470429) or webcast at the provided URL [1]. A replay of the call will be available through August 29, 2025, accessible by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers, with the access code: 52876 [1].
Milestone Scientific specializes in developing innovative injection technologies and instruments for medical, dental, and cosmetic applications. Their proprietary DPS Dynamic Pressure Sensing Technology® is a key platform for advancing next-generation devices, ensuring precise and efficient injections while enhancing patient comfort and safety [1].
References:
[1] https://www.stocktitan.net/news/MLSS/milestone-scientific-schedules-second-quarter-2025-financial-results-i3uss6kp2pi2.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet